Oxford BioMedica (OXB) Hits New 52-Week High at $11.54

Shares of Oxford BioMedica plc (LON:OXB) reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as GBX 11.54 ($0.16) and last traded at GBX 10.94 ($0.15), with a volume of 23000000 shares. The stock had previously closed at GBX 10.94 ($0.15).

Separately, Peel Hunt reiterated a “buy” rating and issued a GBX 13 ($0.18) target price on shares of Oxford BioMedica in a research note on Monday.

In related news, insider Lorenzo Tallarigo purchased 30,436 shares of the firm’s stock in a transaction dated Monday, October 23rd. The shares were purchased at an average price of GBX 9 ($0.12) per share, with a total value of £2,739.24 ($3,714.73). Insiders bought a total of 90,662 shares of company stock worth $815,958 in the last three months.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by Markets Daily and is the property of of Markets Daily. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this piece can be viewed at https://www.themarketsdaily.com/2018/01/11/oxford-biomedica-oxb-hits-new-52-week-high-at-11-54.html.

About Oxford BioMedica

Oxford BioMedica plc is a gene and cell therapy company. The Company is engaged in lentiviral vector and cell therapy research, development and production. The Company’s segments include Partnering, and R&D. The Partnering segment provides lentiviral vector bioprocessing and process development services to partners.

Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply